| Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin L Arabi, A Badiee, F Mosaffa, MR Jaafari Journal of controlled release 220, 275-286, 2015 | 180 | 2015 |
| Crystal habit modifications of ibuprofen and their physicomechanical characteristics HA Garekani, F Sadeghi, A Badiee, SA Mostafa, AR Rajabi-Siahboomi, ... Drug development and industrial pharmacy 27 (8), 803-809, 2001 | 165 | 2001 |
| The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in … MR Jaafari, A Badiee, A Khamesipour, A Samiei, D Soroush, MT Kheiri, ... Vaccine 25 (32), 6107-6117, 2007 | 119 | 2007 |
| Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas M Amin, A Badiee, MR Jaafari International journal of pharmaceutics 458 (2), 324-333, 2013 | 114 | 2013 |
| Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends A Badiee, VH Shargh, A Khamesipour, MR Jaafari Vaccine 31 (5), 735-749, 2013 | 98 | 2013 |
| The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen A Badiee, A Khamesipour, A Samiei, D Soroush, VH Shargh, MT Kheiri, ... Experimental parasitology 132 (4), 403-409, 2012 | 93 | 2012 |
| Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region M Amin, M Mansourian, GA Koning, A Badiee, MR Jaafari, ... Journal of Controlled Release 220, 308-315, 2015 | 86 | 2015 |
| Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205 A Badiee, N Davies, K McDonald, K Radford, H Michiue, D Hart, M Kato Vaccine 25 (25), 4757-4766, 2007 | 84 | 2007 |
| Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes A Badiee, MR Jaafari, A Khamesipour Experimental parasitology 115 (2), 127-134, 2007 | 84 | 2007 |
| Redox-sensitive nanoscale drug delivery systems for cancer treatment E Mirhadi, M Mashreghi, MF Maleki, SH Alavizadeh, L Arabi, A Badiee, ... International journal of pharmaceutics 589, 119882, 2020 | 80 | 2020 |
| P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer S Shariat, A Badiee, SA Jalali, M Mansourian, M Yazdani, SA Mortazavi, ... Cancer letters 355 (1), 54-60, 2014 | 74 | 2014 |
| Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model SA Moosavian, K Abnous, A Badiee, MR Jaafari Colloids and Surfaces B: Biointerfaces 139, 228-236, 2016 | 73 | 2016 |
| Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN M Mansourian, A Badiee, SA Jalali, S Shariat, M Yazdani, M Amin, ... Immunology letters 162 (1), 87-93, 2014 | 70 | 2014 |
| Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis AA Momtazi-Borojeni, MR Jaafari, A Badiee, M Banach, A Sahebkar BMC medicine 17, 1-15, 2019 | 68 | 2019 |
| Preparation, characterization and in vivo evaluation of alginate-coated chitosan and trimethylchitosan nanoparticles loaded with PR8 influenza virus for nasal immunization J Mosafer, AH Sabbaghi, A Badiee, S Dehghan, M Tafaghodi Asian Journal of Pharmaceutical Sciences 14 (2), 216-221, 2019 | 64 | 2019 |
| Coencapsulation of CpG Oligodeoxynucleotides with Recombinant Leishmania major Stress-Inducible Protein 1 in Liposome Enhances Immune Response and … A Badiee, MR Jaafari, A Samiei, D Soroush, A Khamesipour Clinical and vaccine immunology 15 (4), 668-674, 2008 | 64 | 2008 |
| MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer P Zamani, JG Navashenaq, AR Nikpoor, M Hatamipour, RK Oskuee, ... Journal of Controlled Release 303, 223-236, 2019 | 63 | 2019 |
| Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA) H Firouzmand, A Badiee, A Khamesipour, VH Shargh, SH Alavizadeh, ... Acta tropica 128 (3), 528-535, 2013 | 63 | 2013 |
| Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis VH Shargh, MR Jaafari, A Khamesipour, I Jaafari, SA Jalali, A Abbasi, ... Vaccine 30 (26), 3957-3964, 2012 | 61 | 2012 |
| Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system AA Momtazi-Borojeni, MR Jaafari, A Badiee, A Sahebkar Atherosclerosis 283, 69-78, 2019 | 59 | 2019 |
Mahmoud Reza JaafariProf. of Pharmaceutics and Pharmaceutical Nanotechnology在 mums.ac.ir 的电子邮件经过验证
